Sun Pharma, Cassiopea SpA ink permit and supply arrangements for acne treatment drug Winlevi Kumar Jeetendra | July 26, 2021 New Delhi, Jul 26 (PTI) Drug major Sun Pharma on Monday said it has signed license and supply agreements with Cassiopea SpA for acne treatment drug Winlevi in the US and Canada. Sun Pharmaceutical Industries and Cassiopea SpA on Monday announced the signing of license and supply agreements for Winlevi (clascoterone cream 1 per cent) …
BDR Pharma inks permit concurrence with DRDO to deliver COVID-19 drug 2-DG Kumar Jeetendra | July 26, 2021 BDR Pharma on Monday said it has inked a licensing pact with the Defence Research and Development Organisation (DRDO) to manufacture, distribute, and market COVID-19 drug 2-Deoxy-D-Glucose (2-DG) in the country. BDR Pharma has inked a pact with the Defence Research and Development Establishment (DRDE) and the Institute of Nuclear Medicine and Allied Sciences (INMAS) …
FDC introduced Favipiravir oral suspension to treat COVID-19 in India Kumar Jeetendra | July 12, 2021 Pharma firm FDC Ltd on Monday said it has launched oral suspension of Favipiravir to treat mild to moderate cases of COVID-19 in the country. This prescription-only Favenza oral suspension is currently available at all retail medical outlets and hospital pharmacies across India, FDC said in a statement. Convenient loading dosage of the oral suspension …
Alembic Pharma gets USFDA endorsement for anti-depressant drug Kumar Jeetendra | July 8, 2021 Drug firm Alembic Pharmaceuticals on Thursday said it has received approval from the US health regulator for Desipramine Hydrochloride tablets used in the treatment of depression. The approved product is therapeutically equivalent to the reference listed drug product Norpramin tablets of Validus Pharmaceuticals LLC. The company has received approval from the US Food and Drug …
Pfizer, Moderna vaccines cut COVID-19 danger by 91%: Study Kumar Jeetendra | July 8, 2021 People who receive COVID-19 vaccines by Pfizer and Moderna are up to 91 per cent less likely to develop the disease, according to a US study which also suggests that the preventives reduce the severity of symptoms and duration in those who still get an infection. The research, published in the New England Journal of …
Israel to send 700,000 Pfizer dosages to South Korea in trade bargain Kumar Jeetendra | July 6, 2021 Israel is sending 700,000 coronavirus vaccine doses to South Korea in exchange for a future shipment of the jabs, Prime Minister Naftali Bennett said Tuesday. In a statement, Bennett said Israel will transfer the Pfizer vaccines to South Korea in an effort to inoculate more of the Asian nation’s citizens this month. South Korea will …
Optima Laboratory Resource Management System V2021.1 Software Release Announcement Kumar Jeetendra | July 2, 2021 Madrid, Spain – 01 July 2021 – – We are delighted to announce the new Optima Laboratory Resource Management System – LRMS version 2021.1. released by July 1st, 2021. It is a major milestone incorporating a sophisticated engine that automates the complex scheduling process of the laboratory resources. Optima’s algorithm combines all information collected in …
Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19 Kumar Jeetendra | June 29, 2021 India. June 29, 2021 – Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”), Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, hereafter referred to as “Dr. Reddy’s”), Emcure Pharmaceuticals Limited (hereafter referred to as “Emcure”), Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, …
Glenmark Pharma gets USFDA gesture for inhaltion drug Kumar Jeetendra | June 23, 2021 Drug maker Glenmark Pharma on Wednesday said it had received approval from the US health regulator for Arformoterol Tartrate Inhalation Solution, used to treat conditions like chronic bronchitis and emphysema, in the US market. The approved product is a generic version of Brovana Inhalation Solution, 15 mcg/2 mL, of Sunovion Pharmaceuticals Inc. “Glenmark Pharmaceuticals has …
Brazil probes Health Ministry arrangement to purchase Covaxin vaccine Kumar Jeetendra | June 23, 2021 Brazil’s federal prosecutor’s office is investigating possible irregularities in a Health Ministry contract to purchase 20 million doses of the Covaxin vaccine manufactured by Indian laboratory Bharat Biotech. The agreement signed in February commits the ministry to pay USD 320 million – at a cost of USD 15 per vaccine dose – to Precisa Medicamentos, …
Cipla receives final approval for generic version of Sunovion Pharmaceuticals, Inc.’s Arformoterol Tartrate Inhalation Solution Kumar Jeetendra | June 23, 2021 Mumbai, India, June 23, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg / 2 mL from the United States Food and Drug Administration (US FDA). Cipla’s Arformoterol …
AstraZeneca COVID-19 immunization connected to uncommon neurological disorder in India, UK Kumar Jeetendra | June 22, 2021 Eleven people who received the AstraZeneca-Oxford COVID-19 vaccine have developed a rare neurological disorder called Guillain-Barre syndrome, clinicians in India and England have reported in two separate studies. While seven cases were reported from a medical centre in Kerala, where about 1.2 million people were administered the AstraZeneca COVID-19 vaccine, known as Covishield in India, …
